Polycystic liver diseases: Advanced insights into the molecular mechanisms

Maria J. Perugorria, Tatyana V. Masyuk, Jose J. Marin, Marco Marzioni, Luis Bujanda, Nicholas F La Russo, Jesus M. Banales

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Polycystic liver diseases are genetic disorders characterized by progressive bile duct dilatation and/or cyst development. The large volume of hepatic cysts causes different symptoms and complications such as abdominal distension, local pressure with back pain, hypertension, gastro-oesophageal reflux and dyspnea as well as bleeding, infection and rupture of the cysts. Current therapeutic strategies are based on surgical procedures and pharmacological management, which partially prevent or ameliorate the disease. However, as these treatments only show short-term and/or modest beneficial effects, liver transplantation is the only definitive therapy. Therefore, interest in understanding the molecular mechanisms involved in disease pathogenesis is increasing so that new targets for therapy can be identified. In this Review, the genetic mechanisms underlying polycystic liver diseases and the most relevant molecular pathways of hepatic cystogenesis are discussed. Moreover, the main clinical and preclinical studies are highlighted and future directions in basic as well as clinical research are indicated.

Original languageEnglish (US)
Pages (from-to)750-761
Number of pages12
JournalNature Reviews Gastroenterology and Hepatology
Volume11
Issue number12
DOIs
StatePublished - Dec 11 2014
Externally publishedYes

Fingerprint

Cysts
Choledochal Cyst
Inborn Genetic Diseases
Liver
Therapeutics
Back Pain
Gastroesophageal Reflux
Liver Transplantation
Dyspnea
Rupture
Dilatation
Pharmacology
Hemorrhage
Hypertension
Pressure
Polycystic liver disease
Infection
Research
Direction compound
Clinical Studies

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Perugorria, M. J., Masyuk, T. V., Marin, J. J., Marzioni, M., Bujanda, L., La Russo, N. F., & Banales, J. M. (2014). Polycystic liver diseases: Advanced insights into the molecular mechanisms. Nature Reviews Gastroenterology and Hepatology, 11(12), 750-761. https://doi.org/10.1038/nrgastro.2014.155

Polycystic liver diseases : Advanced insights into the molecular mechanisms. / Perugorria, Maria J.; Masyuk, Tatyana V.; Marin, Jose J.; Marzioni, Marco; Bujanda, Luis; La Russo, Nicholas F; Banales, Jesus M.

In: Nature Reviews Gastroenterology and Hepatology, Vol. 11, No. 12, 11.12.2014, p. 750-761.

Research output: Contribution to journalArticle

Perugorria, MJ, Masyuk, TV, Marin, JJ, Marzioni, M, Bujanda, L, La Russo, NF & Banales, JM 2014, 'Polycystic liver diseases: Advanced insights into the molecular mechanisms', Nature Reviews Gastroenterology and Hepatology, vol. 11, no. 12, pp. 750-761. https://doi.org/10.1038/nrgastro.2014.155
Perugorria, Maria J. ; Masyuk, Tatyana V. ; Marin, Jose J. ; Marzioni, Marco ; Bujanda, Luis ; La Russo, Nicholas F ; Banales, Jesus M. / Polycystic liver diseases : Advanced insights into the molecular mechanisms. In: Nature Reviews Gastroenterology and Hepatology. 2014 ; Vol. 11, No. 12. pp. 750-761.
@article{7949453839534fc7bada04c8adf6ac18,
title = "Polycystic liver diseases: Advanced insights into the molecular mechanisms",
abstract = "Polycystic liver diseases are genetic disorders characterized by progressive bile duct dilatation and/or cyst development. The large volume of hepatic cysts causes different symptoms and complications such as abdominal distension, local pressure with back pain, hypertension, gastro-oesophageal reflux and dyspnea as well as bleeding, infection and rupture of the cysts. Current therapeutic strategies are based on surgical procedures and pharmacological management, which partially prevent or ameliorate the disease. However, as these treatments only show short-term and/or modest beneficial effects, liver transplantation is the only definitive therapy. Therefore, interest in understanding the molecular mechanisms involved in disease pathogenesis is increasing so that new targets for therapy can be identified. In this Review, the genetic mechanisms underlying polycystic liver diseases and the most relevant molecular pathways of hepatic cystogenesis are discussed. Moreover, the main clinical and preclinical studies are highlighted and future directions in basic as well as clinical research are indicated.",
author = "Perugorria, {Maria J.} and Masyuk, {Tatyana V.} and Marin, {Jose J.} and Marco Marzioni and Luis Bujanda and {La Russo}, {Nicholas F} and Banales, {Jesus M.}",
year = "2014",
month = "12",
day = "11",
doi = "10.1038/nrgastro.2014.155",
language = "English (US)",
volume = "11",
pages = "750--761",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Polycystic liver diseases

T2 - Advanced insights into the molecular mechanisms

AU - Perugorria, Maria J.

AU - Masyuk, Tatyana V.

AU - Marin, Jose J.

AU - Marzioni, Marco

AU - Bujanda, Luis

AU - La Russo, Nicholas F

AU - Banales, Jesus M.

PY - 2014/12/11

Y1 - 2014/12/11

N2 - Polycystic liver diseases are genetic disorders characterized by progressive bile duct dilatation and/or cyst development. The large volume of hepatic cysts causes different symptoms and complications such as abdominal distension, local pressure with back pain, hypertension, gastro-oesophageal reflux and dyspnea as well as bleeding, infection and rupture of the cysts. Current therapeutic strategies are based on surgical procedures and pharmacological management, which partially prevent or ameliorate the disease. However, as these treatments only show short-term and/or modest beneficial effects, liver transplantation is the only definitive therapy. Therefore, interest in understanding the molecular mechanisms involved in disease pathogenesis is increasing so that new targets for therapy can be identified. In this Review, the genetic mechanisms underlying polycystic liver diseases and the most relevant molecular pathways of hepatic cystogenesis are discussed. Moreover, the main clinical and preclinical studies are highlighted and future directions in basic as well as clinical research are indicated.

AB - Polycystic liver diseases are genetic disorders characterized by progressive bile duct dilatation and/or cyst development. The large volume of hepatic cysts causes different symptoms and complications such as abdominal distension, local pressure with back pain, hypertension, gastro-oesophageal reflux and dyspnea as well as bleeding, infection and rupture of the cysts. Current therapeutic strategies are based on surgical procedures and pharmacological management, which partially prevent or ameliorate the disease. However, as these treatments only show short-term and/or modest beneficial effects, liver transplantation is the only definitive therapy. Therefore, interest in understanding the molecular mechanisms involved in disease pathogenesis is increasing so that new targets for therapy can be identified. In this Review, the genetic mechanisms underlying polycystic liver diseases and the most relevant molecular pathways of hepatic cystogenesis are discussed. Moreover, the main clinical and preclinical studies are highlighted and future directions in basic as well as clinical research are indicated.

UR - http://www.scopus.com/inward/record.url?scp=84927176336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927176336&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2014.155

DO - 10.1038/nrgastro.2014.155

M3 - Article

C2 - 25266109

AN - SCOPUS:84927176336

VL - 11

SP - 750

EP - 761

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 12

ER -